Limited protection against foot-and-mouth disease virus (FMDV) after injection of RNA extracted from yeast was observed in 1960 (8, 33) . More recently, a synthetic double-stranded polynucleotide (poly I: C) induced resistance, presumably related to interferon induction, against infection by FMDV in mice (19, 30) . As reported for other viruses (18, 22) , maximal protection against FMDV after poly I:C injection occurred for only a limited time. Induction of a prolonged antiviral state would be a necessary requisite in the consideration of an agent for possible use in the control of foot-and-mouth disease.
A number of other nonviral synthetic compounds of defined composition have antiviral activity which, in part, is probably related to interferon-mediated protection (9, 11, 12, (20) (21) (22) (23) 26) . Several of these agents induce long-lasting effects (9) ; notably, divinyl ether-maleic anhydride copolymer (pyran)-induced resistance may persist for 2 months (10, 22) . Recent reports suggested that protection of adult mice (19) and guinea pigs (R. Sellers, personal communication) against FMDV could be attained by pretreatment with pyran copolymer. Del.) were prepared in phosphate-buffered saline (PBS) with 0.1 M magnesium and calcium ions (19) . To hasten the dissolution of pyran, gentle heating (45 C) was occasionally employed. The pH was adjusted to 7.2 by using 6 N NaOH after which the pyran solution was sterilized by filtration through 0.45-,um Nalgene disposable filters.
Mice. All mice were produced at this laboratory. The results given in Table 3 clearly demonstrate that pyran stimulated resistance in infant mice against the seven FMDV types tested. The survival and protective index experiments were done with different randomized groups of mice and are not strictly comparable. Virus inactivation. Stock virus and pyran, in concentrations of 0.05 to 5 mg/ml, were mixed and incubated (22) , and viral infectivity was subsequently assayed in mice and BKC cultures. The results of one such experiment with 2 mg of pyran per ml are given in Table 4 . At this level of pyran or at the others tested no direct inhibition of FMDV was observed. Pyran induces interferon (9, 10, 19, 20, 22, 23, 25, 27) , stimulates the immunological response (5; W. Regelson, Int. Symp. Interferon, in press), and produces a biphasic phagocytic reticuloendothelial response with inhibition followed by stimulation of liver and spleen cells (W. Regelson et al., Int. Symp. Interferon, in press). Evidence of toxic effects after pyran administration have been reported (22, 23, 25) . Because of these varied effects, mechanisms other than interferon induction must be considered in interpreting pyran-induced resistance (9, 10, 22, 25, 28) .
Pyran directly inhibits mengovirus, vesicular stomatitis virus, Friend leukemia virus, Semliki Forest virus, and echovirus 9 (10, 12, 22, 25) and to a lesser extent vaccinia virus (20) , and yet there was no inhibition of plaquing efficiency or reduction in lethality for infant mice after incubating FMDV with this polymer (Table 4) . Sellers (personal communication) was similarly unable to demonstrate interaction of FMDV with pyran. The relatively high protective index against FMDV infection observed immediately after pyran injection (Fig. 1) probably does not therefore reflect direct inhibition, although such interactions may have occurred within the peritoneal cavity of the mouse.
Statolon, synthetic polynucleotides, and lipopolysaccharides may initiate the release of "preformed" interferon (39-41) or, as recently postulated by Ho and Ke (16) , the induction of "preinterferon." These investigators suggest that an antiviral state is maintained after stimulation with agents similar to polyribonucleotides by the retention of preinterferon within the cell. Pyran-like endotoxin (3, 13, 24) may damage cell membranes. Polynucleotides associated with such cellular destruction (14, 25) might be the initiators of a preinterferon state reflected by the resistance found with simultaneous injections of pyran and FMDV (Fig. 1) .
The transient antiviral state occurring 4 hr after pyran administration (Fig. 1 ) may also be due to localized preformed interferon or interferon-forming subunits, or it may represent the conversion of preinterferon to interferon (16 (31, 32) .
Although pyran and other polyanions may block virus adsorption or release (12, 34) , stimulation of the reticuloendothelial system may be the prime mechanism whereby the resistant state is manifested (15, 22, (24) (25) (26) (27) (28) . A number of interferon-inducing agents appear to have adjuvanting effects on antibody titers (2-4, 14, 17, 35, 37, 38 ). Freund's adjuvant, which did not induce interferon but which stimulated subsequent virus-induced interferon, delayed the appearance of neutralizing antibody (15) , an observation further implicating the involvement of the recticuloendothelial system in both interferon and immune responses. The exact mechanism whereby resistance is conferred must await the results of additional experimentation, however.
